(Q35561988)

8 August 2017

1 reference

title

Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment (English)

1 reference

hepatic veno-occlusive disease

8 August 2017

main subject

1 reference

1

Martha Wadleigh

0 references

author name string

Vincent Ho

2

1 reference

8 August 2017

Parisa Momtaz

3

1 reference

8 August 2017

Paul Richardson

4

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14564177

22 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00062752-200311000-00010

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Current Opinion in Hematology

22 March 2024

published in

1 reference

8 August 2017

volume

10

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

451-462

1 reference

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches

22 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis

22 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

22 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Cytokine cascades in acute graft-versus-host disease

22 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

22 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms

22 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Acta Pathologica Japonica

22 March 2024

15

37

1961

Shirai

1987

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Sublobular distribution of transferases and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver

22 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients

22 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Glutathione defense in non-parenchymal cells

22 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

22 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat

22 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation

22 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications

22 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation

22 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers

22 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

22 March 2024

41

83

1082

Ferra

1998

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality

22 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

22 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen

22 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation

22 March 2024

45

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Multiple organ dysfunction syndrome in bone marrow transplantation

22 March 2024

50

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Plasma levels of D-dimer and circulating endothelial adhesion molecules in veno-occlusive disease of the liver following allogeneic bone marrow transplantation

22 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Plasma thrombopoietin levels in marrow transplant patients with veno-occlusive disease of the liver

22 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

22 March 2024

54

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation

22 March 2024

55

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients

22 March 2024

56

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation

22 March 2024

58

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection

22 March 2024

59

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver

22 March 2024

63

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells

22 March 2024

64

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia

22 March 2024

65

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Management of hepatic sinusoidal obstruction syndrome following treatment with gemtuzumab ozogamicin (Mylotarg).

22 March 2024

66

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

22 March 2024

67

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

A human Mix-like homeobox gene MIXL shows functional similarity to Xenopus Mix.1.

22 March 2024

68

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

22 March 2024

69

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Venoocclusive disease of the liver following bone marrow transplantation

22 March 2024

70

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation

22 March 2024

71

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

22 March 2024

73

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease

22 March 2024

74

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease

22 March 2024

75

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic venous outflow obstruction: evaluation with pulsed duplex sonography

22 March 2024

76

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver

22 March 2024

77

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Color-flow imaging sonography of portal and hepatic vein flow to monitor fibrinolytic therapy with r-TPA for veno-occlusive disease following myeloablative treatment

22 March 2024

78

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

MR imaging findings in two patients with hepatic veno-occlusive disease following bone marrow transplantation.

22 March 2024

79

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients

22 March 2024

81

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

22 March 2024

82

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Non-myeloablative stem cell transplants

22 March 2024

83

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Non-myeloablative hematopoietic stem cell transplantation

22 March 2024

84

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

22 March 2024

89

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

22 March 2024

90

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients

22 March 2024

92

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Glutamine and vitamin E in the treatment of hepatic veno-occlusive disease following high-dose chemotherapy

22 March 2024

93

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

22 March 2024

95

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation

22 March 2024

99

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

22 March 2024

101

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment

22 March 2024

102

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients

22 March 2024

103

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation

22 March 2024

105

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

22 March 2024

107

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines

22 March 2024

108

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Analogues of pyridoxal isonicotinoyl hydrazone (PIH) as potential iron chelators for the treatment of neoplasia

22 March 2024

111

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Hepatic veno-occlusive disease following hematopoietic stem cell transplantation

22 March 2024

112

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation

22 March 2024

115

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist.

22 March 2024

117

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide

22 March 2024

118

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro

22 March 2024

119

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous veins

22 March 2024

120

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders

22 March 2024

123

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man

22 March 2024

124

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

A new antithrombotic agent in the treatment of acute renal failure due to hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura.

22 March 2024

127

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells

22 March 2024

130

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation

22 March 2024

132

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide

22 March 2024

135

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

22 March 2024

136

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

22 March 2024

137

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation

22 March 2024

142

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Gastroenterología y Hepatología

22 March 2024

144

23

177

Alvarez

2000

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

22 March 2024

145

1 reference

https://api.crossref.org/works/10.1097/00062752-200311000-00010

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference